Evidence map›Paper›PMID 41333113›Full record

ArticleUrology case reports2026

Double trouble: A novel case report of synchronous bilateral renal cell carcinoma of differing histology.

Andrew Shanholtzer, Sahith Kaki, Shane Daugherty, Dongping Shi, Mazen Abdelhady

Abstract readCase Reports
In one paragraph

Article in Urology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Andrew ShanholtzerDetroit Medical Center, Department of Urology, Detroit, MI, USA.
Sahith KakiLake Erie College of Osteopathic Medicine, Erie, PA, USA.
Shane DaughertyDetroit Medical Center, Department of Urology, Detroit, MI, USA.
Dongping ShiDetroit Medical Center, Department of Pathology, Detroit, MI, USA.
Mazen AbdelhadyDetroit Medical Center, Department of Urology, Detroit, MI, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Renal cell carcinomas account for 2-3 % of all malignancies. In non-familial syndrome patients, another kidney tumor synchronous, antecedent, or subsequent to diagnosis of RCC is relatively rare. It is very rare for the kidney tumor to be malignant and of differing pathology altogether. We herein describe a 67-year old male with bilateral synchronous masses treated with open bilateral adrenal sparing radical nephrectomy. His final pathology was interestingly found to have novel, differing aggressive cancers: a TFE3-rearranged RCC and a grade 4 WHO clear cell RCC.

Indexed as

Synchronous renal tumorsTFE3 rearranged renal cell carcinoma

Identifiers

PMID41333113
PMCPMC12666450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.